S-22 Elucidation of Molecular Mechanism Underlying Amyloid-Beta Peptide Aggregation and Its Neurotoxicity Expression and Inhibition of the Biochemical Processes by Beneficial Synthetic and Natural Compounds with Low-Molecular Weights – New Approaches to Fundamental Treatment and Prevention of Alzheimer’s Disease – S22-1 Conformational regulation of amyloid b-peptide by lipid membranes and metal ions S22-2 A search for antiamyloidogenic compounds based on a nucleation-dependent polymerization model S22-3 Ganglioside cluster-mediated aggregation and cytotoxicity of amyloid beta-peptide: molecular mechanism and inhibition S22-4 Preventive action of nobiletin, a component of AURANTII NOBILIS PERICARPIUM with anti-dementia activity, against  amyloid-beta peptide-induced neurotoxicity expression and memory impairment S22-5 Development of Anti-Alzheimer’s Disease Drugs Based on beta-Amyloid hypothesis